Comparison of different growth curves in the assessment of extrauterine growth restriction in very low birth weight preterm infants
Göster/ Aç
Erişim
info:eu-repo/semantics/embargoedAccessTarih
2023Yazar
Yazıcı, AybükeBüyüktiryaki, Mehmet
Sarı, Fatma Nur
Akın, Mustafa Şenol
Ertekin, Ömer
Alyamaç Dizdar, Evrim
Üst veri
Tüm öğe kaydını gösterKünye
Yazıcı, A., Büyüktiryaki, M., Sarı, F. N., Akın, M. Ş., Ertekin, Ö. ve Alyamaç Dizdar, E. (2023). Comparison of different growth curves in the assessment of extrauterine growth restriction in very low birth weight preterm infants. Archives de Pediatrie, 30(1), 31-35. https://dx.doi.org/10.1016/j.arcped.2022.11.008Özet
Background: Preterm infants are at risk of extrauterine growth restriction (EUGR) and associated complications in the long term. Growth curves are important in assessing postnatal growth in these infants. The aim of this study was to determine the prevalence of EUGR in preterm infants and the factors associated with EUGR using two different growth curves. Methods: We retrospectively evaluated 596 preterm infants with birth weight ≤1500 g. Small for gestational age (SGA) was defined as birth weight <10th percentile for gestational age. EUGR was defined as discharge weight z score <−2. All z scores were determined using both the Fenton 2013 and Intergrowth-21st (IG-21) growth curves. Results: The infants’ median gestational age was 28 weeks (27–29) and median birth weight was 1080 g (900–1243). The prevalence of SGA was 9.2% with IG-21 curves and 5% with Fenton curves (p < 0.001). The median discharge weight was 2060 g (1860–2363). The prevalence of EUGR was significantly higher with the Fenton curves than with the IG-21 curves (38% vs. 31.7%, p < 0.001). The mean discharge weight z score was −1.82±1.29 with Fenton and −1.44±1.49 with IG-21 curves. In multivariate analysis, significant risk factors for EUGR according to the Fenton curves were SGA (odds ratio [OR]: 19.15, 95% confidence interval [CI]: 4.4–82.59), respiratory distress syndrome (RDS) (OR 1.64, 95% CI 1.12–2.4), late neonatal sepsis (LNS) (OR: 2.27, 95% CI: 1.5–3.44), and >16 days to full enteral feeding (OR: 1.8, 95% CI: 1.22–2.68). Similarly, independent risk factors for EUGR according to the IG-21 curve were SGA (OR: 16.3, 95% CI: 7.23–36.9), RDS (OR: 1.81, 95% CI: 1.16–2.83), LNS (OR: 2.29, 95% CI: 1.43–3.68), and >16 days to full enteral feeding (OR: 2.11, 95% CI: 1.38–3.23). Conclusion: The growth curves used for diagnosis may lead to differences in EUGR rates in intensive care units and the factors identified as associated with EUGR. At-risk infants should be evaluated for EUGR and their weight and nutritional support should be monitored carefully. Comparisons of long-term outcomes are needed to assess the suitability of growth curves used for EUGR follow-up.
WoS Q Kategorisi
Q3Scopus Q Kategorisi
Q2Kaynak
Archives de PediatrieCilt
30Sayı
1Koleksiyonlar
- Makale Koleksiyonu [3811]
- PubMed İndeksli Yayınlar Koleksiyonu [4281]
- Scopus İndeksli Yayınlar Koleksiyonu [6647]
- WoS İndeksli Yayınlar Koleksiyonu [6721]
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Strategic design and high-growth firms: A case from Turkey
Sözüer, Aytuğ; Bozaykut Bük, Tuba (Springer, 2018)This chapter focuses on the elements of entrepreneurship and high firm growth phenomenon through a case analysis. The study first defines the fundamental concepts of entrepreneurship and its use as a strategy to yield above ... -
Response to growth hormone treatment in very young patients with growth hormone deficiencies and mini-puberty
Çetinkaya, Semra; Poyrazoğlu, Şükran; Baş, Firdevs; Ercan, Oya; Yıldız, Metin; Adal, Erdal; Bereket, Abdullah; Abalı, Saygın; Aycan, Zehra; Erdeve, Senay Savaş; Berberoğlu, Merih; Şıklar, Zeynep; Tayfun, Meltem; Darcan, Şükran; Mengen, Eda; Bircan, İffet; Jones, Filiz Mine Çizmecioğlu; Şimşek, Enver; Papatya, Esra Deniz; Özbek, Mehmet Nuri; Bolu, Semih; Abacı, Ayhan; Büyükinan, Muammer; Darendeliler, Feyza (Walter de Gruyter Gmbh, 2018)Background: The aim of the study was to assess the response to growth hormone (GH) treatment in very young patients with GH deficiency (GHD) through a national, multi-center study. Possible factors affecting growth response ... -
Common polymorphisms of growth hormone: Growth hormone receptor axis in Turkish children with short stature
Yılmaz Güleç, Elif; Ercan, Oya; Adal, Servet Erdal; Buyru, Ayşe Nur; Yıldız, Metin; Deviren, Ayhan (AVES, 2022)Objective: A single-nucleotide polymorphism of the growth hormone 1 gene, GH1IVS4+90A>T (rs2665802), associated with short stature and a polymorphism of the growth hormone receptor gene, exon 3 deleted variant, associated ...